Latest filing published 07 Dec 2016 for Valeant Pharmaceuticals International, Inc., €250k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Robert L. Rosiello appears in our data through filings on Valeant Pharmaceuticals International, Inc. shares, published by SEDI. We count 11 filings; the first trade dates from 12 June 2015 and the latest from 5 December 2016.
No open-market sale appears; the market trades are 3 purchases worth €4.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 8 share grants.
A typical purchase (the median) is worth €1.7M.
On 7 December 2016 came the latest disclosure, a share grant for €250k in Valeant Pharmaceuticals International, Inc. The last insider purchase was made public on 3 August 2015, 4,103 days ago. Filings reach the SEDI feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations